Please login to the form below

Ozurdex

This page shows the latest Ozurdex news and features for those working in and with pharma, biotech and healthcare.

NICE backs Bayer's Eylea in diabetic eye condition

NICE backs Bayer's Eylea in diabetic eye condition. TheInstitute also recommends Allergan's Ozurdex in final guidance. ... Bayer's Eylea and Allergan's Ozurdex have been recommended for use on the NHS in England to treat diabetic macular oedema (DMO).

Latest news

NICE recommends Ozurdex for diabetic eye condition

NICE recommends Ozurdex for diabetic eye condition. Draft guidance cites implant as option for patients with diabetic macular oedema. ... Ozurdex is injected into the eye once every six months and works by suppressing inflammation and preventing oedema
Fresh approval for Roche's Lucentis as competition heats up

Roche's drug is being challenged in the market by Bayer's Eylea (aflibercept) as well as newer entrants such as Allergan's Ozurdex (intravitreal dexamethasone).
New eye indication for Allergan’s Ozurdex

New eye indication for Allergan’ s Ozurdex. EU approval extends the drug's use to diabetic macular oedema. ... Ozurdex joins a competitive market for DMO, with approved drugs in the EU including Novartis' Lucentis (ranibizumab).
Allergan will start phase III DARPin trials next year

On the plus side, Allergan said the FDA had approved a new indication for its intravitreal implant Ozurdex (dexamethasone), namely the treatment of diabetic macular oedema (DME) in adults who have
NICE against new indication for Novartis' Lucentis

Its draft guidance concluded the ICER for Lucentis in central RVO versus Allergan's Ozurdex (dexamethasone) intravitreal implant, the currently approved treatment, was likely to be over £37, 400 per QALY ... Ozurdex was recommended by NICE earlier this

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Allergan and taking a specialised approach

spasticity associated with stroke and for the ophthalmology treatment Ozurdex in diabetic macular oedema.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Graduate Scientific Editor: DOE

Account Manager: Negotiable

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Writer, Healthcare Advertising, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Account Manager – Healthcare Advertising: Salary TBC

Associate Scientific Director: Salary TBC

Account Director - Digital: Great salary and benefits

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager- 4 days per week or full-time: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Account Director or Senior Account Director: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Medical Writer: Salary is DOE

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Subscribe to our email news alerts

PMHub

Add my company

Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...